Incheon, South Korea

Eunsook Ahn


Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eunsook Ahn: Innovator in Pharmaceutical Composition for Inflammatory Diseases

Introduction

Eunsook Ahn is a notable inventor based in Incheon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment and prevention of inflammatory diseases. His innovative work has led to the development of a unique pharmaceutical composition that utilizes an ethyl acetate fraction of dried extract.

Latest Patents

Eunsook Ahn holds 1 patent related to his invention. The patent describes a pharmaceutical composition for treating and preventing inflammatory diseases, which comprises an ethyl acetate fraction of dried extract as an active ingredient. This composition is refined and concentrated to contain 0.05 to 12% by weight of arctigenin, which serves as an index material. The method for producing this fraction is also detailed in the patent, showcasing Ahn's commitment to advancing medical treatments.

Career Highlights

Eunsook Ahn is associated with Shin-il Pharmaceutical Co., Ltd., where he continues to innovate and contribute to the pharmaceutical industry. His work is characterized by a focus on developing effective treatments for inflammatory conditions, which are prevalent in many patients worldwide.

Collaborations

Eunsook Ahn collaborates with talented individuals in his field, including Jeong Min Lee and Jee Hun Park. Their combined expertise enhances the research and development efforts at Shin-il Pharmaceutical Co., Ltd.

Conclusion

Eunsook Ahn's contributions to pharmaceutical innovations demonstrate his dedication to improving healthcare through effective treatments for inflammatory diseases. His work not only highlights his inventive spirit but also the importance of collaboration in advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…